ArticleJournal of internal medicine2022

Plasma lipopolysaccharide-binding protein is a biomarker for future venous thromboembolism: Results from discovery and validation studies.

Søren Beck Jensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.